AUB ScholarWorks

Low nuclear body formation and tax SUMOylation do not prevent NF-kappaB promoter activation

Show simple item record

dc.contributor.author Bonnet A.
dc.contributor.author Randrianarison-Huetz V.
dc.contributor.author Nzounza P.
dc.contributor.author Nedelec M.
dc.contributor.author Chazal M.
dc.contributor.author Waast L.
dc.contributor.author Pene S.
dc.contributor.author Bazarbachi A.
dc.contributor.author Mahieux R.
dc.contributor.author Benit L.
dc.contributor.author Pique C.
dc.contributor.editor
dc.date 2012
dc.date.accessioned 2017-10-05T15:41:37Z
dc.date.available 2017-10-05T15:41:37Z
dc.date.issued 2012
dc.identifier 10.1186/1742-4690-9-77
dc.identifier.isbn
dc.identifier.issn 17424690
dc.identifier.uri http://hdl.handle.net/10938/18098
dc.description.abstract Background: The Tax protein encoded by Human T-lymphotropic virus type 1 (HTLV-1) is a powerful activator of the NF-κB pathway, a property critical for HTLV-1-induced immortalization of CD4+ T lymphocytes. Tax permanently stimulates this pathway at a cytoplasmic level by activating the IκB kinase (IKK) complex and at a nuclear level by enhancing the binding of the NF-κB factor RelA to its cognate promoters and by forming nuclear bodies, believed to represent transcriptionally active structures. In previous studies, we reported that Tax ubiquitination and SUMOylation play a critical role in Tax localization and NF-κB activation. Indeed, analysis of lysine Tax mutants fused or not to ubiquitin or SUMO led us to propose a two-step model in which Tax ubiquitination first intervenes to activate IKK while Tax SUMOylation is subsequently required for promoter activation within Tax nuclear bodies. However, recent studies showing that ubiquitin or SUMO can modulate Tax activities in either the nucleus or the cytoplasm and that SUMOylated Tax can serve as substrate for ubiquitination suggested that Tax ubiquitination and SUMOylation may mediate redundant rather than successive functions.Results: In this study, we analyzed the properties of a new Tax mutant that is properly ubiquitinated, but defective for both nuclear body formation and SUMOylation. We report that reducing Tax SUMOylation and nuclear body formation do not alter the ability of Tax to activate IKK, induce RelA nuclear translocation, and trigger gene expression from a NF-κB promoter. Importantly, potent NF-κB promoter activation by Tax despite low SUMOylation and nuclear body formation is also observed in T cells, including CD4+ primary T lymphocytes. Moreover, we show that Tax nuclear bodies are hardly observed in HTLV-1-infected T cells. Finally, we provide direct evidence that the degree of NF-κB activation by Tax correlates with the level of Tax ubiquitination, but not SUMOylation.Conclusions: These data reveal that the formation of Tax nuclear bodies, previously associated to transcriptional activities in Tax-transfected cells, is dispensable for NF-κB promoter activation, notably in CD4+ T cells. They also provide the first evidence that Tax SUMOylation is not a key determinant for Tax-induced NF-κB activation. © 2012 Bonnet et al.; licensee BioMed Central Ltd.
dc.format.extent
dc.language English
dc.publisher LONDON
dc.relation.ispartof Publication Name: Retrovirology; Publication Year: 2012; Volume: 9;
dc.relation.ispartofseries
dc.relation.uri
dc.source Scopus
dc.subject.other
dc.title Low nuclear body formation and tax SUMOylation do not prevent NF-kappaB promoter activation
dc.type Article
dc.contributor.affiliation Bonnet, A., INSERM, U1016, Institut Cochin, 22 rue Méchain, 75014 Paris, France, CNRS, UMR8104, Paris, France, Université Paris Descartes, Sorbonne Paris Cité, Paris, France
dc.contributor.affiliation Randrianarison-Huetz, V., INSERM, U1016, Institut Cochin, 22 rue Méchain, 75014 Paris, France, CNRS, UMR8104, Paris, France, Université Paris Descartes, Sorbonne Paris Cité, Paris, France
dc.contributor.affiliation Nzounza, P., INSERM, U1016, Institut Cochin, 22 rue Méchain, 75014 Paris, France, CNRS, UMR8104, Paris, France, Université Paris Descartes, Sorbonne Paris Cité, Paris, France
dc.contributor.affiliation Nedelec, M., INSERM, U1016, Institut Cochin, 22 rue Méchain, 75014 Paris, France, CNRS, UMR8104, Paris, France, Université Paris Descartes, Sorbonne Paris Cité, Paris, France
dc.contributor.affiliation Chazal, M., INSERM, U1016, Institut Cochin, 22 rue Méchain, 75014 Paris, France, CNRS, UMR8104, Paris, France, Université Paris Descartes, Sorbonne Paris Cité, Paris, France
dc.contributor.affiliation Waast, L., INSERM, U1016, Institut Cochin, 22 rue Méchain, 75014 Paris, France, CNRS, UMR8104, Paris, France, Université Paris Descartes, Sorbonne Paris Cité, Paris, France
dc.contributor.affiliation Pene, S., INSERM, U1016, Institut Cochin, 22 rue Méchain, 75014 Paris, France, CNRS, UMR8104, Paris, France, Université Paris Descartes, Sorbonne Paris Cité, Paris, France
dc.contributor.affiliation Bazarbachi, A., Department of Internal Medicine, American University of Beirut, Beirut, Lebanon
dc.contributor.affiliation Mahieux, R., INSERM, U758, Ecole Normale Supérieure de Lyon, Lyon, France
dc.contributor.affiliation Bénit, L., INSERM, U1016, Institut Cochin, 22 rue Méchain, 75014 Paris, France, CNRS, UMR8104, Paris, France, Université Paris Descartes, Sorbonne Paris Cité, Paris, France
dc.contributor.affiliation Pique, C., INSERM, U1016, Institut Cochin, 22 rue Méchain, 75014 Paris, France, CNRS, UMR8104, Paris, France, Université Paris Descartes, Sorbonne Paris Cité, Paris, France
dc.contributor.authorAddress Pique, C.; INSERM, U1016, Institut Cochin, 22 rue Méchain, 75014 Paris, France; email: claudine.pique@inserm.fr
dc.contributor.authorCorporate University: American University of Beirut Medical Center; Faculty: Faculty of Medicine; Department: Internal Medicine;
dc.contributor.authorDepartment Internal Medicine
dc.contributor.authorDivision
dc.contributor.authorEmail claudine.pique@inserm.fr
dc.contributor.faculty Faculty of Medicine
dc.contributor.authorInitials Bonnet, A
dc.contributor.authorInitials Randrianarison-Huetz, V
dc.contributor.authorInitials Nzounza, P
dc.contributor.authorInitials Nedelec, M
dc.contributor.authorInitials Chazal, M
dc.contributor.authorInitials Waast, L
dc.contributor.authorInitials Pene, S
dc.contributor.authorInitials Bazarbachi, A
dc.contributor.authorInitials Mahieux, R
dc.contributor.authorInitials Benit, L
dc.contributor.authorInitials Pique, C
dc.contributor.authorOrcidID
dc.contributor.authorReprintAddress Pique, C (reprint author), INSERM, U1016, Inst Cochin, 22 Rue Mechain, F-75014 Paris, France.
dc.contributor.authorResearcherID
dc.contributor.authorUniversity American University of Beirut Medical Center
dc.description.cited Au Ping-Yee Billie, 2007, Adv Exp Med Biol, V597, P32; Baydoun H, 2007, GENE, V386, P191, DOI 10.1016-j.gene.2006.09.008; Bex F, 1997, J VIROL, V71, P3484; BHAT NK, 1993, VIROLOGY, V196, P15, DOI 10.1006-viro.1993.1450; Boxus M, 2008, RETROVIROLOGY, V5, DOI 10.1186-1742-4690-5-76; Chiari E, 2004, J VIROL, V78, P11823, DOI 10.1128-JVI.78.21.11823-11832.2004; Chin KT, 2007, CANCER RES, V67, P1072, DOI 10.1158-0008-5472.CAN-06-3053; Durkin SS, 2008, J BIOL CHEM, V283, P36311, DOI 10.1074-jbc.M804931200; Fryrear KA, 2012, BLOOD, V119, P1173, DOI 10.1182-blood-2011-06-358564; Fryrear KA, 2009, J VIROL, V83, P5339, DOI 10.1128-JVI.00232-09; Garcia-Mata R, 1999, J CELL BIOL, V146, P1239, DOI 10.1083-jcb.146.6.1239; Gatza ML, 2007, RETROVIROLOGY, V4, DOI 10.1186-1742-4690-4-95; Harhaj EW, 1999, J BIOL CHEM, V274, P22911, DOI 10.1074-jbc.274.33.22911; Harhaj NS, 2007, J BIOL CHEM, V282, P4185, DOI 10.1074-jbc.M611031200; Journo C, 2009, PLOS PATHOG, V5, DOI 10.1371-journal.ppat.1000521; Journo C, 2009, FUTURE MICROBIOL, V4, P425, DOI [10.2217-fmb.09.13, 10.2217-FMB.09.13]; Kfoury Y, 2008, ONCOGENE, V27, P1665, DOI 10.1038-sj.onc.1210804; Kfoury Y, 2011, BLOOD, V117, P190, DOI 10.1182-blood-2010-05-285742; Lamsoul I, 2005, MOL CELL BIOL, V25, P10391, DOI 10.1128-MCB.25.23.10391-10406.2005; Lavorgna A, 2012, J VIROL, V86, P3357, DOI 10.1128-JVI.06456-11; Lodewick J, 2011, VIRUSES-BASEL, V3, P829, DOI 10.3390-v3060829; Nasr R, 2006, BLOOD, V107, P4021, DOI 10.1182-blood-2005-09-3572; Peloponese JM, 2004, J VIROL, V78, P11686, DOI 10.1128-JVI.78.21.11686-11695.2004; Peloponese JM, 2007, INT J HEMATOL, V86, P101, DOI 10.1532-IJH97.07087; Petropoulos L, 1996, VIROLOGY, V225, P52, DOI 10.1006-viro.1996.0574; POIESZ BJ, 1980, P NATL ACAD SCI-BIOL, V77, P7415, DOI 10.1073-pnas.77.12.7415; Robek MD, 1999, J VIROL, V73, P4856; Semmes OJ, 1996, J VIROL, V70, P6347; Shembade N, 2010, SCIENCE, V327, P1135, DOI 10.1126-science.1182364; Shembade N, 2008, NAT IMMUNOL, V9, P254, DOI 10.1038-ni1563; Shembade N, 2007, J VIROL, V81, P13735, DOI 10.1128-JVI.01790-07; Shibata Y, 2011, J BIOCHEM, V150, P679, DOI 10.1093-jb-mvr106; Sun SC, 2005, ONCOGENE, V24, P5952, DOI 10.1038-sj.onc.1208969; Sun Y, 2003, CANCER BIOL THER, V2, P623; SUZUKI T, 1994, ONCOGENE, V9, P3099; Taylor JM, 2008, APOPTOSIS, V13, P733, DOI 10.1007-s10495-008-0208-7; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146-annurev.immunol.021908.132641; Wang YT, 2011, J MOL BIOL, V414, P1, DOI 10.1016-j.jmb.2011.09.027; Yasunaga J, 2011, J VIROL, V85, P6212, DOI 10.1128-JVI.00079-11; Ye H, 1999, MOL CELL, V4, P321, DOI 10.1016-S1097-2765(00)80334-2; Yu QS, 2008, BIOCHEM BIOPH RES CO, V365, P189, DOI 10.1016-j.bbrc.2007.10.172
dc.description.citedCount 10
dc.description.citedTotWOSCount 11
dc.description.citedWOSCount 11
dc.format.extentCount 1
dc.identifier.articleNo 77
dc.identifier.coden
dc.identifier.pubmedID 23009398
dc.identifier.scopusID 84866538111
dc.identifier.url
dc.publisher.address 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
dc.relation.ispartofConference
dc.relation.ispartofConferenceCode
dc.relation.ispartofConferenceDate
dc.relation.ispartofConferenceHosting
dc.relation.ispartofConferenceLoc
dc.relation.ispartofConferenceSponsor
dc.relation.ispartofConferenceTitle
dc.relation.ispartofFundingAgency
dc.relation.ispartOfISOAbbr Retrovirology
dc.relation.ispartOfIssue
dc.relation.ispartOfPart
dc.relation.ispartofPubTitle Retrovirology
dc.relation.ispartofPubTitleAbbr Retrovirology
dc.relation.ispartOfSpecialIssue
dc.relation.ispartOfSuppl
dc.relation.ispartOfVolume 9
dc.source.ID WOS:000310008700001
dc.type.publication Journal
dc.subject.otherAuthKeyword Leukemia
dc.subject.otherAuthKeyword NF-kappaB
dc.subject.otherAuthKeyword Nuclear speckles
dc.subject.otherAuthKeyword Retrovirus
dc.subject.otherAuthKeyword SUMO
dc.subject.otherAuthKeyword Ubiquitin
dc.subject.otherChemCAS I kappa B kinase, 209902-66-9
dc.subject.otherChemCAS CREB1 protein, human
dc.subject.otherChemCAS Cyclic AMP Response Element-Binding Protein
dc.subject.otherChemCAS Gene Products, tax
dc.subject.otherChemCAS I-kappa B Kinase, 2.7.11.10
dc.subject.otherChemCAS IKBKG protein, human
dc.subject.otherChemCAS Luciferases, Renilla, 1.13.12.5
dc.subject.otherChemCAS NF-kappa B
dc.subject.otherChemCAS Recombinant Fusion Proteins
dc.subject.otherChemCAS SUMO-1 Protein
dc.subject.otherChemCAS tax protein, Human T-lymphotrophic virus 1
dc.subject.otherIndex I kappa B kinase
dc.subject.otherIndex immunoglobulin enhancer binding protein
dc.subject.otherIndex Tax protein
dc.subject.otherIndex transcription factor RelA
dc.subject.otherIndex article
dc.subject.otherIndex CD4+ T lymphocyte
dc.subject.otherIndex cell nucleus
dc.subject.otherIndex cell nucleus inclusion body
dc.subject.otherIndex controlled study
dc.subject.otherIndex cytoplasm
dc.subject.otherIndex gene expression
dc.subject.otherIndex human
dc.subject.otherIndex human cell
dc.subject.otherIndex Human T cell leukemia virus 1
dc.subject.otherIndex nonhuman
dc.subject.otherIndex promoter region
dc.subject.otherIndex sumoylation
dc.subject.otherIndex ubiquitination
dc.subject.otherIndex Amino Acid Substitution
dc.subject.otherIndex CD4-Positive T-Lymphocytes
dc.subject.otherIndex Cell Line
dc.subject.otherIndex Cyclic AMP Response Element-Binding Protein
dc.subject.otherIndex Gene Products, tax
dc.subject.otherIndex Genes, Reporter
dc.subject.otherIndex Host-Pathogen Interactions
dc.subject.otherIndex Human T-lymphotropic virus 1
dc.subject.otherIndex Humans
dc.subject.otherIndex I-kappa B Kinase
dc.subject.otherIndex Intranuclear Space
dc.subject.otherIndex Luciferases, Renilla
dc.subject.otherIndex Microscopy, Confocal
dc.subject.otherIndex NF-kappa B
dc.subject.otherIndex Promoter Regions, Genetic
dc.subject.otherIndex Protein Binding
dc.subject.otherIndex Protein Processing, Post-Translational
dc.subject.otherIndex Protein Transport
dc.subject.otherIndex Recombinant Fusion Proteins
dc.subject.otherIndex Signal Transduction
dc.subject.otherIndex SUMO-1 Protein
dc.subject.otherIndex Sumoylation
dc.subject.otherIndex Transcription, Genetic
dc.subject.otherIndex Transcriptional Activation
dc.subject.otherIndex Ubiquitination
dc.subject.otherIndex Human T-lymphotropic virus 1
dc.subject.otherKeywordPlus VIRUS TYPE-1 TAX
dc.subject.otherKeywordPlus B ACTIVATION
dc.subject.otherKeywordPlus CELLULAR-TRANSFORMATION
dc.subject.otherKeywordPlus GENE-EXPRESSION
dc.subject.otherKeywordPlus ONCOPROTEIN TAX
dc.subject.otherKeywordPlus HTLV-I
dc.subject.otherKeywordPlus PROTEIN
dc.subject.otherKeywordPlus UBIQUITINATION
dc.subject.otherKeywordPlus TRANSCRIPTION
dc.subject.otherKeywordPlus LOCALIZATION
dc.subject.otherWOS Virology


Files in this item

Files Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record

Search AUB ScholarWorks


Browse

My Account